DK58387A - Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling - Google Patents

Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling

Info

Publication number
DK58387A
DK58387A DK058387A DK58387A DK58387A DK 58387 A DK58387 A DK 58387A DK 058387 A DK058387 A DK 058387A DK 58387 A DK58387 A DK 58387A DK 58387 A DK58387 A DK 58387A
Authority
DK
Denmark
Prior art keywords
preparation
alfa
procedure
active ingredient
pharmaceutical preparation
Prior art date
Application number
DK058387A
Other languages
English (en)
Other versions
DK164202C (da
DK164202B (da
DK58387D0 (da
Inventor
Helmut Franz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK58387D0 publication Critical patent/DK58387D0/da
Publication of DK58387A publication Critical patent/DK58387A/da
Publication of DK164202B publication Critical patent/DK164202B/da
Application granted granted Critical
Publication of DK164202C publication Critical patent/DK164202C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
DK058387A 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling DK164202C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863603444 DE3603444A1 (de) 1986-02-05 1986-02-05 Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3603444 1986-02-05

Publications (4)

Publication Number Publication Date
DK58387D0 DK58387D0 (da) 1987-02-04
DK58387A true DK58387A (da) 1987-08-06
DK164202B DK164202B (da) 1992-05-25
DK164202C DK164202C (da) 1992-10-19

Family

ID=6293372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK058387A DK164202C (da) 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Country Status (20)

Country Link
EP (1) EP0231816B1 (da)
JP (1) JPS62209024A (da)
KR (1) KR870007698A (da)
AT (1) ATE63823T1 (da)
AU (1) AU601712B2 (da)
CA (1) CA1295242C (da)
DD (1) DD284602A5 (da)
DE (2) DE3603444A1 (da)
DK (1) DK164202C (da)
ES (1) ES2028796T3 (da)
FI (1) FI86144C (da)
GR (1) GR3002270T3 (da)
HU (1) HU196560B (da)
IE (1) IE59697B1 (da)
IL (1) IL81472A0 (da)
NO (1) NO169638C (da)
NZ (1) NZ219169A (da)
PH (1) PH24377A (da)
PT (1) PT84243B (da)
ZA (1) ZA87793B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275804A (en) * 1986-02-25 1994-01-04 E. B. Michaels Research Associates, Inc. Process and composition for oral hygiene
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3803312A1 (de) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Verwendung eines interferonenthaltenden gels
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE68917883T2 (de) * 1988-05-06 1995-02-23 Toray Industries Stabile interferon-beta-zusammensetzung.
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
EP0607275A4 (en) * 1991-10-11 1995-02-22 Mark Cedric Gillies TREATMENT OF OPHTHALMIC FIBROSE WITH ALPHA INTERFERON.
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
JP4536194B2 (ja) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 安定な注射用製剤
CA2402589C (en) * 2000-03-07 2011-02-01 Sanjay Garg Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
WO2003037375A1 (fr) * 2001-11-02 2003-05-08 Sekisui Chemical Co., Ltd. Substance d'induction de cytokine et instrument d'induction de cytokine
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
CA2761963C (en) * 2009-05-29 2018-03-20 Filligent Limited Composition for use in decreasing the transmission of human pathogens
NZ629769A (en) 2012-03-01 2016-09-30 Firststring Res Inc Topical gels containing alpha connexin c-terminal (act) peptides
JP6081156B2 (ja) * 2012-11-15 2017-02-15 アルケア株式会社 ハイドロゲル
DE102012222365A1 (de) 2012-12-05 2014-06-05 Aesculap Ag Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
CN105530950A (zh) * 2013-06-09 2016-04-27 艾弗兰纳特有限公司 包含Gc-巨噬细胞活化因子的组合物及其用途
MX2019008104A (es) 2017-01-31 2019-10-17 Kimberly Clark Co Composicion antibacteriana que incluye un ester del acido benzoico y metodos de inhibicion del crecimiento bacteriano mediante el uso de la misma.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
EP0139286B1 (en) * 1983-10-14 1991-08-21 Sumitomo Pharmaceuticals Company, Limited Prolonged sustained-release preparations
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60260523A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd インタ−フエロンの凍結乾燥医薬組成物

Also Published As

Publication number Publication date
ATE63823T1 (de) 1991-06-15
DK164202C (da) 1992-10-19
DD284602A5 (de) 1990-11-21
CA1295242C (en) 1992-02-04
EP0231816A3 (en) 1987-09-23
AU6829287A (en) 1987-08-06
AU601712B2 (en) 1990-09-20
NO169638B (no) 1992-04-13
DE3770280D1 (de) 1991-07-04
ZA87793B (en) 1988-10-26
PT84243B (pt) 1989-09-14
HUT43494A (en) 1987-11-30
NO870441L (no) 1987-08-06
FI86144C (fi) 1992-07-27
JPS62209024A (ja) 1987-09-14
EP0231816B1 (de) 1991-05-29
ES2028796T3 (es) 1992-07-16
PT84243A (de) 1987-03-01
NZ219169A (en) 1990-04-26
IE59697B1 (en) 1994-03-23
HU196560B (en) 1988-12-28
PH24377A (en) 1990-06-13
KR870007698A (ko) 1987-09-21
FI870457A0 (fi) 1987-02-03
DK164202B (da) 1992-05-25
DK58387D0 (da) 1987-02-04
GR3002270T3 (en) 1992-12-30
IE870295L (en) 1987-08-05
DE3603444A1 (de) 1987-08-06
NO870441D0 (no) 1987-02-04
NO169638C (no) 1992-07-22
FI870457A (fi) 1987-08-06
IL81472A0 (en) 1987-09-16
FI86144B (fi) 1992-04-15
EP0231816A2 (de) 1987-08-12

Similar Documents

Publication Publication Date Title
DK58387A (da) Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling
DK203787D0 (da) Praeparat til nasal administrering
SE8800731D0 (sv) Phenyl carbamate
DK253988D0 (da) Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK144885A (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK409786D0 (da) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
DK238089D0 (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK180086D0 (da) 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK454588A (da) Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
DK184686D0 (da) (aminoalkylthio)hydroxydibenzoxepiner, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
DK454185D0 (da) Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner

Legal Events

Date Code Title Description
PBP Patent lapsed